The store will not work correctly when cookies are disabled.
4-Acetamido-5-benzamido-2-fluoro benzoic acid
ID: ALA552203
PubChem CID: 45270059
Max Phase: Preclinical
Molecular Formula: C16H13FN2O4
Molecular Weight: 316.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)Nc1cc(F)c(C(=O)O)cc1NC(=O)c1ccccc1
Standard InChI: InChI=1S/C16H13FN2O4/c1-9(20)18-14-8-12(17)11(16(22)23)7-13(14)19-15(21)10-5-3-2-4-6-10/h2-8H,1H3,(H,18,20)(H,19,21)(H,22,23)
Standard InChI Key: ZQDKVKXSUSRCJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
-1.1059 1.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1059 0.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3914 0.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3230 0.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3230 1.4118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3914 1.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3914 2.6493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1059 3.0618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3230 3.0618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8204 1.8243 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.3914 -0.6507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3230 -1.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0375 -0.6507 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3230 -1.8882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0375 0.1743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7520 0.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4664 0.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7520 1.4118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1809 0.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8954 0.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8954 -0.6507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1809 -1.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4664 -0.6507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
12 14 1 0
6 7 1 0
4 15 1 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 1 0
16 18 2 0
7 9 2 0
17 19 2 0
4 5 1 0
19 20 1 0
1 10 1 0
20 21 2 0
2 3 1 0
21 22 1 0
3 11 1 0
22 23 2 0
23 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 316.29 | Molecular Weight (Monoisotopic): 316.0859 | AlogP: 2.73 | #Rotatable Bonds: 4 |
Polar Surface Area: 95.50 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.25 | CX Basic pKa: ┄ | CX LogP: 2.10 | CX LogD: -1.33 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.81 | Np Likeness Score: -1.24 |
References
1. Magesh S, Savita V, Moriya S, Suzuki T, Miyagi T, Ishida H, Kiso M.. (2009) Human sialidase inhibitors: design, synthesis, and biological evaluation of 4-acetamido-5-acylamido-2-fluoro benzoic acids., 17 (13): [PMID:19450982] [10.1016/j.bmc.2009.04.065] |